New Key Statistics Module, Z-Score and F-Score
SZSE:300238 Key Ratios
Market Cap ¥ M | 2,709.89 |
Enterprise Value ¥ M | 2,719.34 |
P/E(ttm) | 113.56 |
PE Ratio without NRI | 82.42 |
Forward PE Ratio | -- |
Price/Book | 5.06 |
Price/Sales | 6.92 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 382.00 |
EPS (TTM) ¥ | 0.09 |
Beneish M-Score | -2.86 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 103.95 |
EV-to-EBITDA | 103.95 |
PEG | -- |
Shares Outstanding M | 265.16 |
Net Margin (%) | 6.08 |
Operating Margin % | 12.31 |
Pre-tax Margin (%) | 6.46 |
Quick Ratio | 1.38 |
Current Ratio | 1.84 |
ROA % (ttm) | 3.40 |
ROE % (ttm) | 4.46 |
ROIC % (ttm) | 5.09 |
Dividend Yield % | -- |
Altman Z-Score | 7.67 |
SZSE:300238 Number of Guru Trades
SZSE:300238 Volume of Guru Trades
Gurus Latest Trades with SZSE:300238
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300238 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guanhao Biotech Co Ltd Insider Transactions
No Available Data